MedMen Enterprises Inc. (OTC: MMNFF), the Los Angeles-based cannabis company acquired the medical-marijuana dispensary chain PharmaCann in a $682 million all-stock transaction this week. The deal is the largest marijuana company acquisition in the U.S. to date.

Medmen employs 700 people with a dozen cannabis storefronts, as well as operations in California, Nevada, and New York.

Trending dispensary locations

The company currently has 14 dispensaries on the hippest shopping streets the world over. Among locations are Venice Beach’s Abbot Kinney Boulevard, the Las Vegas Strip, and Fifth Ave, New York.

MedMen doubles U.S. footprint

MedMen’s U.S. footprint doubled because of the PharmaCann acquisition. The acquired company has 10 facilities in the Midwest, and that includes Michigan, where voters will decide on legalization next month.

“This is a transformative acquisition that will create the largest US cannabis company in the world’s largest cannabis market,” MedMen CEO Adam Bierman said in a statement.

Upscale pot

Medmen leads companies in the upscaling U.S. pot. The company’s recreational use stores are designed to follow a specific aesthetic: open spaces with reclaimed-wood tables and iPads. Bud pods in plastic cases offer shoppers an olfactory taste of the product. Salespeople in red T-shirts with the logo ‘Shop. It’s legal.’ assist as cannaseurs.

Apparently, the company is going for an Apple store vibe. But the unmistakable smell of skunk wafts throughout.

Mainstreaming pot

“Our overall goal is mainstreaming marijuana,” says the CEO. The company targets “nine-to-five dads who previously came home and opened up a bottle or had a shot or took a Xanax.”

“For someone who’s never used marijuana before, and now their friends are telling them it’s legal and they want to go see what it’s about, I’m going to make that experience something that feels normal. Something that feels good, that they’d be comfortable integrating into their weekly routine.”

As regulations relax, growth estimates for the pot industry range from $50 billion to $500 Billion.

“I think historically, if you look at YouTube, you see people taking dab hits on these devices that look scary to me,” Bierman says. “And then getting excited about how they got stuck on the couch for eight hours. That’s not what people want. That’s not the future.”

As a result, MedMen’s products include vape pens, edibles like gummies and marijuana-infused confections. Carrying over 1,000 products, each is placed enticingly on wall displays. While cannabis smokers currently account for 60% of MedMen’s sales, that number is projected to decrease with the introduction of new ways of consuming cannabis.